Stocks and Investing
Stocks and Investing
Thu, May 2, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robbie Marcus Maintained (ATRC) at Buy with Decreased Target to $34 on, May 2nd, 2024
Robbie Marcus of JP Morgan, Maintained "AtriCure, Inc." (ATRC) at Buy with Decreased Target from $42 to $34 on, May 2nd, 2024.
Robbie has made no other calls on ATRC in the last 4 months.
There are 3 other peers that have a rating on ATRC. Out of the 3 peers that are also analyzing ATRC, 0 agree with Robbie's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robbie
- Suraj Kalia of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $32 on, Tuesday, April 23rd, 2024
- Danielle Antalffy of "UBS" Maintained at Strong Buy with Increased Target to $58 on, Friday, February 16th, 2024
- Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $42 on, Friday, February 16th, 2024
Contributing Sources